SARAH BEAULIEU: Open Payments
NPI 1205333689 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 60 payments from 15 companies in 2025. Trend: 2023 $142 · 2024 $457 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $184 |
| Otsuka America Pharmaceutical, Inc. | 6 | $110 |
| Collegium Pharmaceutical, Inc. | 5 | $108 |
| Alkermes, Inc. | 4 | $106 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| ABBVIE INC. | 4 | $74 |
| Almatica Pharma LLC | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
Products named: COBENFY, Jornay PM, REXULTI, ARISTADA, UZEDY, CAPLYTA, INGREZZA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
